Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

Frank‐Jan H. Drost(Erasmus MC), Nicole Benfante, Prokar Dasgupta(King's College London), Paul C. Boutros(University of California, Los Angeles), Caroline M. Moore(University College London Hospitals NHS Foundation Trust), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Bruce J. Trock(Johns Hopkins University), Christopher P. Filson(Emory University), Behfar Ehdaie(NewYork–Presbyterian Hospital), Anders Bjartell(Lund University), J. Rubio‐Briones, Kerri Beckmann(The University of Adelaide), Byung Ha Chung, Jonas Hugosson(Sahlgrenska University Hospital), Daan Nieboer(Erasmus MC), Vincent J. Gnanapragasam(Addenbrooke's Hospital), Todd M. Morgan(University of Michigan), Jeri Kim(The University of Texas MD Anderson Cancer Center), Lee Lui Shiong(Singapore General Hospital), Kenneth Muir(Manchester Academic Health Science Centre), Andrew Hayen(University of Technology Sydney), Antti Rannikko(Royal Free London NHS Foundation Trust), Monique J. Roobol(Erasmus MC), Michael Fahey, Brian T. Denton(University of Michigan), Tim Hulsen(Philips (Netherlands)), Arnauld Villers(Université de Lille), Peter R. Carroll(University of California, San Francisco), Theodorus van der Kwast(Erasmus MC), Wei Guo(Peking University), Mark Frydenberg(Monash University), Lukas Hefermehl, Tom Pickles, Cees de Jonge, Artitaya Lophatananon(Manchester Academic Health Science Centre), Laurence Klotz(University of Toronto), Antoinette S. Perry, Yoshiyuki Kakehi(Kagawa University), Ewout W. Steyerberg(Erasmus MC), Liying Zhang, Wim van der Linden(Philips (Netherlands)), Eric Hyndman, Chris H. Bangma(Erasmus MC), Xinge Ji(Cleveland Clinic), Mieke Van Hemelrijck(Ghent University Hospital)
European Urology
August 24, 2019
Cited by 24


Related Papers